Skip to main content

Month: January 2021

Bridgetown 2 Holdings Limited Announces Pricing of $260 Million Initial Public Offering

Hong Kong, Jan. 25, 2021 (GLOBE NEWSWIRE) — Bridgetown 2 Holdings Limited (the “Company”) announced today the pricing of its initial public offering of 26,000,000 Class A ordinary shares at a price of $10.00 per share. The Class A shares will be listed on The Nasdaq Capital Market (the “Nasdaq”) and trade under the ticker symbol “BTNB” beginning on January 26, 2021. The offering is expected to close on January 28, 2021.Bridgetown 2 Holdings Limited is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue a business combination target in any business or industry, the Company intends to focus on a target with operations or prospective operations in the technology,...

Continue reading

SouthGobi Announces the Voting Results of the Shareholders’ Meeting

VANCOUVER, British Columbia, Jan. 25, 2021 (GLOBE NEWSWIRE) — SouthGobi Resources Ltd. (TSX: SGQ, HK: 1878) (“SouthGobi” or the “Company”) is pleased to announce the voting results of the annual and special meeting of shareholders of the Company (the “Shareholders’ Meeting”) held in Vancouver, Canada on January 21, 2021. At the Meeting, the majority of the Company’s shareholders voted in favour of the following matters as set out in the Company’s management proxy circular dated December 9, 2020 (the “Circular”), a copy of which is available under the Company’s profile on SEDAR at www.sedar.com.The voting results are as follows:Appointment of Auditors – BDO Limited, Certified Public Accountants (Practicing), Hong Kong, was appointed as auditor of the Company to hold office for the ensuring year or until their successors are...

Continue reading

BridgeBio Pharma, Inc. Prices Upsized Offering of $650 Million Convertible Senior Notes

PALO ALTO, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (the “Company,” “we” or “BridgeBio”) announced today the pricing of $650 million aggregate principal amount of 2.25% convertible senior notes due 2029 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering was upsized from the previously announced offering of $400 million aggregate principal amount of notes. In connection with the offering, the Company granted the initial purchasers an option to purchase up to an additional $97.5 million aggregate principal amount of notes. The sale of the notes is expected to close on January 28, 2021, subject to customary closing conditions.The notes will bear interest at...

Continue reading

Brown & Brown, Inc. Announces Promotion of Stephen M. Boyd to Lead Wholesale Brokerage Segment

DAYTON BEACH, Fla., Jan. 25, 2021 (GLOBE NEWSWIRE) — Brown & Brown, Inc. (NYSE:BRO) (the “Company”) today announced the promotion of Stephen M. Boyd to the position of Executive Vice President and President of the Company’s Wholesale Brokerage Segment.Mr. Boyd most recently served as the Company’s Senior Vice President of Technology, Innovation, and Digital Strategy. He joined the Company’s subsidiary, Arrowhead General Insurance Agency, Inc., in 1995 and has served in various roles, including as Arrowhead’s President and Chief Operating Officer, President of Arrowhead’s Commercial Division, and Arrowhead’s Chief Information Officer. He has also served as a senior leader within Brown & Brown’s National Programs Segment.Anthony T. Strianese, who previously served as the President of the Company’s Wholesale Segment, has...

Continue reading

Tokens.com and COIN Hodl Announce Proposed Reverse Takeover

Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States.TORONTO, Jan. 25, 2021 (GLOBE NEWSWIRE) — COIN Hodl Inc. (TSXV: COIN) (“COIN”) is pleased to announce that it has entered into a letter of intent dated effective January 21, 2021 (the “LOI”) with Tokens.com Inc. (“Tokens”), a privately held Ontario corporation. The LOI sets out the general terms and conditions pursuant to which COIN has agreed to acquire all of the issued and outstanding securities of Tokens in exchange for securities of COIN (the “Transaction”).The Transaction will result in the reverse takeover of COIN by Tokens, as contemplated under the policies of the TSX Venture Exchange (the “Exchange”). COIN and Tokens are at arm’s length...

Continue reading

Biotech Acquisition Company Announces Pricing of $200 Million Initial Public Offering

New York, NY, Jan. 25, 2021 (GLOBE NEWSWIRE) — Biotech Acquisition Company (the “Company”), a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses, today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. Although the Company may pursue a business target in any industry or geographic location, the Company intends to focus its search for a target business in the healthcare sector.The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “BIOTU” beginning January 26, 2021. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles...

Continue reading

Amarin Expands Cardiovascular Risk Reduction Patent Infringement Lawsuit to Include Health Care Insurance Provider

DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), announced today an expansion of the scope of its VASCEPA® (icosapent ethyl) cardiovascular (CV) risk reduction patent infringement lawsuit against Hikma Pharmaceuticals PLC to include a health care insurance provider in the United States, Health Net, LLC. The lawsuit was filed in the United States District Court in Delaware. A copy of the amended complaint is available through the FAQ section of the Amarin investor relations website.Multiple healthcare insurance providers and managed care enterprises have respected Amarin’s patent rights. As detailed in the complaint, Health Net is not among them. Through insurance coverage and economic incentives Amarin alleges that Health Net has actively induced pharmacies to dispense,...

Continue reading

Veeco Announces Date for Fourth Quarter and Year-End 2020 Financial Results and Conference Call

PLAINVIEW, N.Y., Jan. 25, 2021 (GLOBE NEWSWIRE) — Veeco Instruments Inc. (NASDAQ: VECO) plans to release its fourth quarter and full year 2020 financial results after the market closes on Thursday, February 11, 2021. The company will host a conference call to review these results starting at 5:00pm ET that day.To join the call, dial 1-866-248-8441 (toll free) or 1-929-477-0577 and use passcode 7940308. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco’s website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website beginning at 8:00pm ET that same evening.About VeecoVeeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our proven ion beam, laser annealing, lithography, MOCVD and single wafer etch & clean...

Continue reading

Educational Development Corporation Announces Record Net Revenues and Earnings Estimates for Fiscal 2021

TULSA, Okla., Jan. 25, 2021 (GLOBE NEWSWIRE) — Educational Development Corporation (“EDC”, or the “Company”) (NASDAQ: EDUC) (http://www.edcpub.com) reports fiscal 2021 net revenue guidance in excess of $200.0 million and fiscal 2021 diluted earnings per share in excess of $1.45 per share.Per Randall White, Chief Executive Officer, “Recently we provided net revenues guidance for fiscal 2021 of approximately $200.0 million and earnings per share estimates between $1.40 and $1.50 per share. We are pleased to provide updated guidance results as we continue to improve through our fiscal fourth quarter. Having said this, I would like to reconfirm to our shareholders that there are significant variances in our quarterly performance results due to typical seasonality. Consequently, the Company evaluates quarterly and year to date results...

Continue reading

Great Southern Bancorp, Inc. Reports Preliminary Fourth Quarter and Annual Earnings of $1.28 and $4.21 Per Diluted Common Share

Preliminary Financial Results and Other Matters for the Quarter and Year Ended December 31, 2020:CECL Adoption: The recently-enacted COVID relief legislation, the Consolidated Appropriations Act, 2021, provides for an optional additional delay for certain bank holding companies to adopt the Current Expected Credit Loss (CECL) accounting standard. Great Southern Bancorp, Inc. (the Company) has elected to delay the initial adoption date of this standard to January 1, 2021, in accordance with guidance approved by the Securities and Exchange Commission. Therefore, the Company’s financial statements for the three months and year ended December 31, 2020, were prepared under the existing incurred loss accounting standard. The adoption of the CECL model during the first quarter of 2021 will require us to recognize a one-time cumulative adjustment...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.